Study guide

11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

Key Takeaways Explain This Topic AI

Autologous cell harvesting systems (e.g., ReCell System) enzymatically disaggregate a small, ultra-thin split-thickness skin biopsy (e.g., 2x2 cm) at the point of care to generate an Autologous Cell Suspension (ACS) containing viable basal keratinocytes, melanocytes, fibroblasts, and Langerhans cells with expansion ratios up to 1:80.

ReCell is utilized as standalone definitive therapy for partial-thickness burns or co-administered over widely meshed autografts (1:3 to 1:5) and dermal templates, accelerating interstitial epithelial bridging, restoring pigmentation, and suppressing hypertrophic scarring.

Cultured Epithelial Autografts (CEA / Epicel) involve laboratory tissue-culture expansion of a patient's own epidermal keratinocytes over 2 to 4 weeks to produce confluent sheets of cultured epithelium; CEA is reserved as a life-saving salvage therapy for massive burns (>70% TBSA) with exhausted donor sites.

Because CEA sheets lack a protective dermis and basement membrane anchoring fibrils (Type VII collagen), they are fragile, highly susceptible to shear and microbial lysis, and exhibit significant contracture unless placed over a vascularized dermal scaffold.

Donor sites frequently cause more severe acute pain than the excised burn wound due to exposed dermal nerve terminals; selection follows an anatomical hierarchy (thighs, buttocks, back, scalp), and modern care prioritizes moisture-retentive, non-adherent dressings under a 'leave alone' protocol to optimize re-epithelialization within 7 to 14 days.

Last updated: August 2026

11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

Core Knowledge: When major burn trauma creates extensive cutaneous deficits, the availability of healthy donor skin becomes the ultimate rate-limiting factor for survival. Modern burn surgery addresses this challenge through two cutting-edge cellular regenerative paradigms: point-of-care autologous cell suspensions (ReCell) and laboratory-expanded cultured epithelial autografts (CEA) . In parallel, optimal management of split-thickness donor sites —often the most excruciatingly painful component of the patient's post-operative recovery—is essential to prevent donor site conversion and facilitate rapid re-harvesting.

1. Autologous Cell Harvesting: The ReCell System

The ReCell Autologous Cell Harvesting Device is an FDA-approved, point-of-care cellular regenerative platform that transforms a tiny, ultra-thin split-thickness skin biopsy into an Autologous Cell Suspension (ACS) within the operating room in approximately 30 minutes. RECELL POINT-OF-CARE WORKFLOW

  • [ Step 1: Biopsy ] Harvest ultra-thin STSG (0.005–0.008"; ~2x2 cm)
  • │
  • ▼
  • [ Step 2: Incubation ] Enzymatic digestion in heated trypsin solution (37°C, 15–20 min)
  • │ (Cleaves dermal-epidermal junction)
  • ▼
  • [ Step 3: Scraping ] Mechanically scrape basal layer to isolate individual cells
  • │
  • ▼
  • [ Step 4: Suspension ] Rinse with buffer solution, filter through micro-pore strainer
  • │ (Yields ACS: Keratinocytes, Melanocytes, Fibroblasts)
  • ▼
  • [ Step 5: Spray Delivery] Aerosolize cell suspension over wound bed / meshed autograft
  • (Expansion ratio up to 1:80; covers up to 320 cm² per 4 cm² biopsy)
  • Cellular Composition and Biological Mechanisms

Unlike isolated cultured keratinocyte sheets, the ReCell suspension delivers a diverse, multi-phenotypic population of uncultured, disaggregated cells directly from the basal and suprabasal layers of the patient's skin:

Basal Keratinocytes (Stem Cells): Proliferate rapidly and migrate outward across the wound bed, initiating multi-focal re-epithelialization islands that rapidly merge.

Melanocytes: Crucial for producing melanin and restoring natural skin pigmentation. Spraying melanocytes dramatically reduces post-burn dyschromia, hypopigmentation, and the "patchwork" cosmetic deformities typical of traditional meshed grafting.

Dermal Papillary Fibroblasts: Synthesize organized extracellular matrix components, balancing collagen remodeling and reducing hypertrophic scar formation.

Langerhans Cells: Restore local cutaneous immune surveillance and antigen-presenting defenses in the newly epithelialized wound.

Clinical Applications and Expansion Ratios

Massive Expansion Ratio: A tiny 2 × 2 cm 2\times 2\text{ cm} 2 × 2 cm ( 4 cm 2 4\text{ cm}^2 4 cm 2 ) biopsy yields enough cellular suspension to cover up to 320 cm 2 320\text{ cm}^2 320 cm 2 of wound area—representing a clinical expansion ratio of up to 1:80 .

Standalone Therapy for Partial-Thickness Burns: In clean superficial-to-deep partial-thickness burns (e.g., pediatric scalds, flash burns), ReCell can be sprayed directly onto debrided wound beds without any sheet autograft, achieving definitive epithelialization within 7 to 10 days with superior cosmetic and scar elasticity outcomes.

Co-Application Over Widely Meshed Autografts: In extensive full-thickness burns, ReCell is sprayed directly over 1:2, 1:3, or 1:4 meshed autografts . The sprayed cells seed the open interstitial diamond spaces, accelerating interstitial closure from 14–21 days down to 5 to 7 days , smoothing the waffle-mesh pattern, and significantly reducing secondary contracture.

2. Cultured Epithelial Autografts (CEA / Epicel)

Cultured Epithelial Autografts (CEA) , commercially available as Epicel , represent a specialized laboratory-based tissue engineering salvage therapy reserved exclusively for massive, catastrophic burns ( > 70 % TBSA >70\%\text{ TBSA} > 70% TBSA ) where autograft donor sites are totally exhausted. CEA / EPICEL LIFECYCLE

  • [ Day 0: Biopsy ] 2–3 full-thickness skin biopsies (2x2 cm) taken from unburned groin/axilla
  • │
  • ▼
  • [ Days 1–21: Culture ] Dispatched to specialized laboratory; keratinocytes isolated and
  • expanded on irradiated murine 3T3 fibroblast feeder layers
  • │
  • ▼
  • [ Days 16–28: Delivery] 2–8 cell-layer thick confluent epidermal sheets attached to
  • petrolatum gauze backings flown directly to burn center
  • │
  • ▼
  • [ Day 21+: Placement ] Meticulously stapled to vascularized wound bed / allograft dermis;
  • immobilized for 7–10 days under specialized non-shear dressings
  • Limitations and Clinical Vulnerabilities of CEA

While life-saving in catastrophic burns, CEA exhibits profound physiological limitations that require highly specialized nursing care:

Total Absence of Dermis: CEA consists only of fragile epidermal keratinocytes without an underlying dermal collagen matrix. Without dermis, CEA lacks mechanical tensile strength and tissue compliance.

Delayed Anchoring Fibril Formation: The structural anchoring fibrils ( Type VII collagen ) that secure the epidermal basement membrane to the underlying dermis require several months to a full year to fully develop. Consequently, CEA sheets are exquisitely fragile; the slightest friction or shear force will cause the cultured epidermis to blister and slough off (epidermolysis).

Extreme Susceptibility to Microbial Lysis: Bacterial colonization (especially Pseudomonas or Proteus ) rapidly digests the delicate single-cell layers, causing total graft loss within hours.

High Cost and Long Lead Time: The 2- to 4-week laboratory culturing window requires the patient to be bridged with cryopreserved allograft in the burn ICU while awaiting CEA delivery.

Optimal Take on Dermal Scaffolds: To improve survival, CEA is ideally placed over a prepared vascularized allograft dermis (Cuono technique) or Integra neodermis, where the cadaveric epidermis has been stripped away leaving only the vascularized human dermal bed.

Comparative Analysis: ReCell vs. CEA vs. Standard STSG

Clinical Parameter ReCell Autologous Suspension Cultured Epithelial Autograft (CEA) Standard Split-Thickness Graft (STSG)

Processing Location Point-of-care (in operating room) Specialized off-site laboratory Operating room (immediate)

Turnaround Time ~30 minutes 16 to 28 days (2–4 weeks) Immediate

Tissue Composition Keratinocytes, Melanocytes, Fibroblasts Pure epidermal keratinocyte sheets Epidermis + intact partial dermis

Expansion Ratio Up to 1:80 Up to 1:1,000+ 1:1 (sheet) to 1:6 (meshed)

Dermal Component Co-applied over dermis or wound bed None (purely epidermal) Contains native dermal collagen/elastin

Mechanical Durability High when combined with meshed STSG Extremely Fragile (blisters easily) High structural tensile strength

Primary Indication 2nd-degree burns; adjunct to meshed STSG Massive burns ( > 70 % TBSA >70\%\text{ TBSA} > 70% TBSA ) salvage Standard full/deep burn wound closure

3. Split-Thickness Donor Site Selection & Management

A split-thickness donor site represents an acute, iatrogenic partial-thickness burn wound created by the surgeon's dermatome. Effective donor site management is critical to promote rapid re-epithelialization, prevent infection, control excruciating pain, and enable repeat harvests in extensive burn injuries. DONOR SITE ANATOMICAL HIERARCHY

  • [ 1. Anterolateral Thighs ] ──► Preferred first-line; large, flat surface, easily dressed
  • [ 2. Buttocks / Flanks ] ──► Excellent thickness; easily concealed cosmetically
  • [ 3. Posterior Trunk/Back ] ──► Large surface area; ideal for massive burn harvesting
  • [ 4. Abdomen / Upper Arms ] ──► Useful secondary sites; caution around joints
  • [ 5. SCALP ] ──► ELITE SITE IN EXTENSIVE BURNS: Rapid 5–7 day healing,
  • repeat harvest 4–6 times, zero cosmetic alopecia
  • [ AVOID / CONTRAINDICATED ] ──► Face, anterior neck, hands, feet, across joint flexures
  • Anatomical Selection Hierarchy

Anterolateral Thighs and Buttocks: The premier first-line donor locations. They offer broad, flat planes for smooth dermatome tracking, adequate dermal thickness, and easy concealment under clothing.

Back and Flanks: Ideal for large surface area harvests in major burns. Positioning requires careful post-operative turning protocols to avoid prolonged pressure ischemia.

The Scalp as an Elite Donor Site: In extensive, massive burn injuries ( > 50 % TBSA >50\%\text{ TBSA} > 50% TBSA ), the scalp represents an invaluable, highly specialized donor site:

Rapid Healing Dynamics: Due to the dense, rich microvascular blood supply of the head and an immense concentration of deep hair follicles (which house robust reservoirs of epithelial stem cells in the follicular bulges), scalp donor sites re-epithelialize extraordinarily fast— typically within 5 to 7 days .

Repeat Harvestability: The scalp can be harvested repeatedly 4 to 6 times or more throughout a single hospitalization without compromising healing capacity.

Cosmetic Hair Preservation: When harvested at standard thin-to-medium depth ( 0.008 to 0.010 inches ), the deep hair roots (located 3 to 5 mm 3\text{ to }5\text{ mm} 3 to 5 mm deep in the subcutaneous fat) remain completely intact, allowing normal hair regrowth with zero permanent alopecia or visible scarring .

Dermatome Harvesting Mechanics and Donor Depth

Power dermatomes (air or electric) are calibrated precisely between 0.010 and 0.014 inches (0.25 to 0.35 mm) for standard STSG harvesting.

Mineral oil is applied to the donor skin to reduce friction and allow smooth dermatome gliding.

The skin is held under taut, uniform two-point tension using wooden tongue depressors or sterile metal guards while the dermatome advances at a steady 45-degree angle.

Neurobiology of Donor Site Pain

Patients universally report that the split-thickness donor site is significantly more painful than the excised, grafted burn wound . The biological rationale is straightforward:

Full-thickness burns destroy all cutaneous nerve endings, rendering the core burn insensible to light touch.

In stark contrast, harvesting an STSG transects millions of superficial A-delta and C nociceptive nerve fibers at the mid-dermal level, leaving raw, unmyelinated nerve endings directly exposed to atmospheric air, mechanical friction, and local inflammatory mediators.

Proactive multimodal pain management—incorporating regional nerve blocks (e.g., Fascia Iliaca Compartment Block for thigh donor sites) , scheduled non-opioid analgesics, and moisture-retentive dressings—is mandatory.

4. Modern Donor Site Dressing Protocols

Donor site healing relies on the migration and proliferation of keratinocytes from surviving deep hair follicles, sebaceous glands, and sweat gland ducts. Contemporary donor site care prioritizes moisture-retentive environments under a "leave alone" paradigm.

Dressing Category Specific Examples Mechanism & Application Clinical Advantages & Nursing Care

Semipermeable Polyurethane Films Tegaderm, Opsite Transparent, moisture-retentive adhesive film applied over clean donor bed. Maintains moist physiological exudate rich in endogenous growth factors; allows continuous visualization; non-adherent. Serosanguinous "fluid blister" accumulates normally; fluid can be aspirated with a sterile needle and patched if leaking.

Impregnated Gauze Xeroform (bismuth tribromophenate), Scarlet Red Fine-mesh gauze impregnated with petrolatum and bismuth applied as single layer. Traditional "open" method; outer gauze removed after 24h, leaving Xeroform to dry into a hard, protective crust. Lifts and curls up spontaneously at edges as re-epithelialization completes (10–14 days); trimmed daily with sterile scissors. Do NOT pull forcefully.

Hydrocolloids & Calcium Alginates DuoDERM, Kaltostat, Algisite Seaweed-derived alginates form a hydrophilic sodium-calcium gel upon contact with wound exudate. High fluid absorption capacity; promotes hemostasis through calcium ion release; highly soothing; reduces dressing change trauma. Ideal for heavily exudative fresh donor sites.

Silver Nylon & Hydrofiber Dressings Aquacel Ag, Acticoat, Silverlon Carboxymethylcellulose hydrofiber or nylon fabric coated with ionic silver ( A g + Ag^+ A g + ). Continuous broad-spectrum antimicrobial barrier for 7 to 14 days; suppresses bacterial colonization; locks in exudate vertically to prevent peri-wound maceration. Left undisturbed until spontaneous separation.

The "Leave-Alone" Nursing Protocol

Prevent Mechanical Stripping: Never prematurely peel or aggressively pull adherent primary donor site dressings (such as Xeroform, Aquacel Ag, or films). Forcibly removing an adherent dressing rips away newly migrating, single-cell epithelial monolayers, converting a superficial donor site into a deep, scarring wound.

Spontaneous Separation: As re-epithelialization reaches completion beneath the dressing (typically days 10 to 14), the dressing naturally detaches from the keratinized skin surface. Nurses trim the non-adherent, curled edges daily with sterile scissors until the entire dressing separates cleanly.